دورية أكاديمية

PAH--DNA Adducts, Cigarette Smoking, GST Polymorphisms, and Breast Cancer Risk.

التفاصيل البيبلوغرافية
العنوان: PAH--DNA Adducts, Cigarette Smoking, GST Polymorphisms, and Breast Cancer Risk.
المؤلفون: McCarty, Kathleen M., Santella, Regina M., Steck, Susan E., Cleveland, Rebecca J., Ahn, Jiyoung, Ambrosone, Christine B., North, Kari, Sagiv, Sharon K., Eng, Sybil M., Teitelbaum, Susan L., Neugut, Alfred I., Gammon, Marilie D.
المصدر: Environmental Health Perspectives; Apr2009, Vol. 117 Issue 4, p552-558, 7p, 5 Charts
مصطلحات موضوعية: BREAST cancer research, POLYCYCLIC aromatic hydrocarbons, DNA adducts, GENETIC polymorphisms, GLUTATHIONE transferase, POLYMERASE chain reaction
مستخلص: BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) may increase breast cancer risk, and the association may be modified by inherited differences in deactivation of PAH intermediates by glutathione S-transferases (GSTs). Few breast cancer studies have investigated the joint effects of multiple GSTs and a PAH biomarker. OBJECTIVES: We estimated the breast cancer risk associated with multiple polymorphisms in the GST gene (GSTA1, GSTM1, GSTP1, and GSTT1) and the interaction with PAH--DNA adducts and cigarette smoking. METHODS: We conducted unconditional logistic regression using data from a population-based sample of women (cases/controls, respectively): GST polymorphisms were genotyped using polymerase chain reaction and matrix-assisted laser desorption/ionization time-of-flight assays (n = 926 of 916), PAH--DNA adduct blood levels were measured by competitive enzyme-linked immunosorbent assay (n = 873 of 941), and smoking status was assessed by in-person questionnaires (n = 943 of 973). RESULTS: Odds ratios for joint effects on breast cancer risk among women with at least three variant alleles were 1.56 [95% confidence interval (CI), 1.13--2.16] for detectable PAH--DNA adducts and 0.93 (95% CI, 0.56--1.56) for no detectable adducts; corresponding odds ratios for three or more variants were 1.18 (95% CI, 0.82--1.69) for ever smokers and 1.44 (95% CI, 0.97--2.14) for never smokers. Neither interaction was statistically significant (p = 0.43 and 0.62, respectively). CONCLUSION: We found little statistical evidence that PAHs interacted with GSTT1, GSTM1, GSTP1, and GSTA1 polymorphisms to further increase breast cancer risk. [ABSTRACT FROM AUTHOR]
Copyright of Environmental Health Perspectives is the property of National Institute of Environmental Health Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00916765
DOI:10.1289/ehp.0800119